Abstract. The mechanisms of hypertrophic cardiomyopathy (HCM) pathogenesis can be investigated by determining the differences between healthy and disease states at the molecular level. In the present study, large-scale transcriptome sequencing was performed to compare mRNA expression in patients with HCM and control groups using an Illumina sequencing platform. Compared with the genome background, 257 differentially expressed genes (DEGs) were identified in which 62 genes were downregulated and 195 genes were upregulated. Reverse transcription-quantitative polymerase chain reaction was performed to validate the expression pattern of certain mRNAs. Gene ontology enrichment and KEGG analysis of mRNAs was conducted to identify the biological modules and pathological pathways associated with the DEGs. To the best of our knowledge, this is the first time study to investigate the differences in mRNA between patients with HCM and normal controls at the transcriptome level. The results of the study will contributed to the understanding of the important molecular mechanisms involved in HCM and aid the selection of key genes to investigate in the future.
Introduction
Myocardial hypertrophy is an initial physiological adaptive response to elevation of blood pressure and pressure overload, it is also a common pathophysiological process involved in various cardiovascular diseases, including hypertension, myocardial infarction, cardiac valvular disease, hypertrophic cardiomyopathy (HCM) (1) . Although the intervention of drug can control blood pressure in the normal range, the myocardial hypertrophy will, inevitably, gradually progress to chronic heart failure (2) . In fact, myocardial hypertrophy is an independent risk factor for cardiovascular disease, exponentially increased risk of cardiovascular mortality (3, 4) . Treatment for myocardial hypertrophy is remains confined to dilation of blood vessels, reducing myocardial contraction force and afterload, rarely directly targeting the formation of myocardial hypertrophy. HCM is a common cause of sudden cardiac arrest in young people, including young athletes (5, 6) . Accordingly, early diagnosis is essential for the prevention of such catastrophic events (7) (8) (9) .
The transcriptome is the collection of all the produced mRNA transcripts within a species or specific cell types (10) . Transcriptome analysis, that investigates gene function and expression from the overall level, revealing the specific molecular mechanisms in biological processes and disease, has been widely used in basic research, clinical diagnosis, drug research and other fields (11, 12) . Based on the high-throughput sequencing platform, transcriptome sequencing technology enables the detection of the overall transcriptional activity of any mRNA species and transcription at the single nucleotide level. Analysis of transcription and expression levels can also identify unknown and rare transcripts, accurately detecting the variable shear loci and coding sequence nucleoside polymorphisms, providing the most comprehensive transcriptional analysis. Compared with the traditional platform of chip hybridization, transcriptome sequencing without advance design of probes for known sequences, transcriptional activity analysis can be performed for any species. It also provides a more precise digital signal and high-throughput analysis with a broader scope, and is a powerful tool for studying transcriptome complexity (10, 13) .
The current study performed large-scale transcriptome sequencing comparing HCM patients and control groups using an Illumina sequencing platform. Differentially expressed genes (DEGs) were examined, and gene ontology (GO) enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis of mRNAs were performed to identify the biological modules and pathological pathways involved in HCM.
Materials and methods

Tissue collection from patients with HCM and healthy individuals.
For the present study, all procedures were approved by the Ethics Committee of the Beijing Anzhen Hospital (Beijing, China). Written informed consent was obtained from all subjects under a general waiver by the institutional review board of Beijing Anzhen Hospital. Hypertrophied myocardial tissues used in this study were obtained from 6 patients with HCM that exhibited severe symptoms and underwent septal myectomy at Department of Cardiac Surgery of Beijing Anzhen Hospital, termed the HY group. Additionally, 6 normal myocardial tissues were excised from 6 healthy individuals that were previously declared brain dead during autopsy that had voluntarily donated their body to Renmin Hospital of Wuhan University (Wuhan, China) for research, and were used as the control group, termed the NH group. Patient characteristics were as follows: Age, 35-57 years, 6 males and 6 females.
Transcript profiling using RNA-sequencing (RNA-Seq). Total RNAs were extracted from samples using RNeasy Mini kit (Qiagen GmbH, Hilden, Germany) according to the manufacturer's instructions. The total RNA samples were initially treated with 1 U/µl DNase I to degrade any potential DNA contamination. Then the mRNA was enriched with 50 µl/sample oligo (dT) magnetic beads (Thermo Fisher Scientific, Inc., Waltham, MA, USA). The samples were mixed with the fragmentation buffer [NEB Next First Strand Synthesis Reaction Buffer (New England BioLabs, Inc., Ipswich, MA, USA)] and fragmented into short fragments of ~200 bps. The first strand of cDNA was synthesized using random hexamer-primers following the manufacturer's protocol (Thermo Fisher Scientific, Inc.). They were incubated for 10 min at 94˚C. The double stranded cDNA was purified with AMPure XP magnetic beads (Beckman Coulter, Inc., Brea, CA, USA). End reparation and 3'-end single nucleotide A addition was performed as previously described (14). Finally, sequencing adaptors (Illumina, Inc., San Diego, CA, USA) were ligated to the fragments and the fragments were amplified by polymerase chain reaction (PCR) according to the Illumina (Illumina, Inc.) instructions. Agilent 2100 Bioanaylzer (Agilent Technologies, Inc., Santa Clara, CA, USA) and ABI StepOnePlus Real-Time PCR System (Thermo Fisher Scientific, Inc.) were used to qualify and quantify the sample library. The library products were sequenced via Illumina HiSeq2000 (Illumina, Inc.).
Read mapping and analysis. By base calling, the original image data produced by the sequencing machine is converted into sequences. Prior to starting further analysis, data filtering is preprocessed to obtain clean reads using in-house Perl scripts based on criterion previously reported (15) . Short Oligonucleotide Analysis Package (SOAP) software (SOAPaligner/soap2; soap.genomics.org.cn/soapaligner. html) was used to map reads into reference sequences and reference gene set (UCSC genome browser; genome.ucsc. edu/; version hg19), in which no more than 2 mismatches were allowed (16) . Annotating the results that from Basic Local Alignment Search Tool (BLAST; version 2.2.23; parameters: -p blastx-e 1e-5 -m7) sequences of the 'non-redundant' NCBI database to the terms of GO using Blast2GO (version 2.2.5; www.blast2go.com; default parameters) (17) . Annotation to the KEGG database was also performed with BLAST (parameters: -p blastx -e 1e-5-m 8).
Gene expression analysis. The gene expression level was calculated using the reads per kilobase per million algorithm (18) . The NOI-seq method (19) was used to screen differentially expressed genes between two groups which is a non-parametric approach for differential expression analysis. (19) . Screening differentially expression genes between the groups requires high correlation among the replicates. The Pearson method was used to obtain coefficients for all genes between every two samples for the reference (data not shown). GO enrichment analysis based on hypergeometric distribution mode provided all GO terms of DEGs that were significantly enriched compared with the genome background, and screened the DEGs with which biological function was significantly correlated. KEGG pathway enrichment identified significantly enriched metabolic pathways or signal transduction pathways associated with the DEGs compared with the whole genome background using hypergeometric distribution. We use WEGO software (wego. genomics.org.cn/cgi-bin/wego/index.pl) to perform the GO function classification of different genes, and understand the functional distribution of different genes at the macro level (20) .
Reverse transcription-quantitative PCR (RT-qPCR).
Total tissue RNA was isolated from NH and HY cardiac tissue samples using TRIzol reagent (Thermo Fisher Scientific, Inc.) and carried out RT was performed using PrimeScript™ II first strand cDNA Synthesis kit (Takara Bio, Inc., Otsu, Japan) according to the manufacturer's instructions. RT-qPCR was performed using ABI 7900HT cycler (Thermo Fisher Scientific, Inc.) and 5-carboxyfluorescein (Sangon Biotech Co., Ltd., Shanghai, China) was used as the fluorophore. The following PCR primer sequences were used: fibromodulin (FMOD) forward (F) 5'-GCT GCT GTA TGT GCG GCT-3' and reverse (R) 5'-AAG TTC ACG ACG TCC ACCAC-3'; fibroblast growth factor (FGF12) F 5'-TTC TCG GAT GGA AAG TCTGG -3' and R 5'-ATC AAG GTG TCC ACA GGGCT-3'; potassium voltage-gated channel interacting protein 2 (KCNIP2) F 5'-AGC GCG ATC CCT CTA CCA-3' and R 5'-GGT GAC ACA CGG TGG ACAAT-3'; corin serine peptidase (CORIN) F 5'-TGT GCT CTC GTT CTC TTGCT-3' and R 5'-GAA TAA CAT CGG ACC CTTGG-3'; connective tissue growth factor (CTGF) F 5'-AAT GAC AAC GCC TCC TGC-3' and R 5'-TGC ACT TTT TGC CCT TCTAA-3'; and hActin F 5'-AGC ACA ATG AAG ATC AAG ATCAT-3' and R 5'-ACT CGT CAT ACT CCT GCT TGC-3'. PCR conditions were as follows: Pre-incubation at 95˚C for 3 min, following by 40 cycles of 95˚C for 3 sec and 60˚C for 20 sec, with a final cycle of 95˚C for 15 sec, 60˚C for 15 sec and 95˚C for 15 sec. Actin was used as an internal control and relative quantification was calculated by the 2 -ΔΔCq method (21) .
Statistical analysis. The statistical significance of GO enrichment and pathway enrichment were analyzed by using the hypergeometric distribution and false discovery rate was calculated to correct the P-value using Bonferroni correction, with P≤0.05 considered to indicate a statistically significant difference. For comparison of two groups using the NOI-seq method, a gene was declared as a DEG with probability is ≥0.8 and fold change ≥2. Data analysis use R version 3.0.1 (www.r-project.org) with the addition of the ggplot2 package (ggplot2.org).
Results
Sequencing saturation analysis and gene coverage. Following sequencing using the HiSeq2000 and raw data filtering, reads were mapped to the reference gene set. The average sample obtained 14,459,386 reads used for further analysis. On average, in each sample the percentage of reads mapped into the gene set was 54.38%, ranging from 48.55 to 62.41%; mapped into the genome was 91.33%, ranging from 90.35 to 92.43%. Sequence saturation analysis demonstrated that the higher the number of reads the more genes that were detected. When the number of reads reached a certain level, the number of detected genes was in a constant state, which implied the detected gene number trended toward saturation (Figs. 1 and 2). Gene coverage was analyzed by the ratio of the number of bases in a gene covered by unique mapping reads. Thus, the RNA-Seq data is sufficient for profiling of the transcriptome differences between HCM patients and normal controls.
Sequencing randomness analysis. The randomness of sequencing, immediate impact subsequent bioinformatics analysis, was analyzed by the distribution of reads on reference genes. As reference genes have different lengths, the reads position on gene was standardized to a relative location, which is the ratio between reads position on the gene and gene length.
The results of distributions of reads on reference genes of each sample suggested that the randomness of RNA fragmentation is acceptable (Figs. 3 and 4) .
DEGs between the groups. The NOI-seq method was performed to screen for DEGs between the HY and NH groups. In total, 19,962 DEGs were detected by comparing the NH group and HY group. Based on filter criteria of probability ≥0.8 and |log2Ratio|≥1, 62 downregulated and 195 upregulated DEGs were identified (Fig. 5) . Thus, 1.29% genes were significantly regulated, which indicates that these genes may be HCM-specific genes. To ascertain possible functions of significantly regulated genes, the heart-specific genes were searched in the Pattern Gene Database (22) and are presented in Table I .
RT-qPCR to validate the expression pattern of mRNA. The mRNA expression of certain significantly regulated genes including CORIN, CTGF, FGF12, FMOD, KCNIP2, was validated using RT-qPCR as they had a significant log2Ratio. All the mRNAs exhibited similar changes in expression pattern as observed by the transcriptome sequencing analysis (Fig. 6 ).
GO functional classification and enrichment analysis of
DEGs. GO annotation is a useful means of assigning functional information to genes employing standardized vocabulary. In the current study, a total of 16,090 genes were annotated into cellular component groups, of which 228 genes were DEGs; 15,165 genes were annotated into molecular function groups, of which 205 genes were DEGs; 14,596 genes were annotated into biological process groups, of which 213 genes were DEGs. Subsequently, GO annotation for DEGs were classified using WEGO software to determine the distribution of gene functions at the macro level, as presented in Fig. 7 . Of the biological process categories, the major categories identified were cellular process (12.7%), metabolic process (8.6%) and multicellular organismal process (8.6%). In molecular function, the most common terms were binding (52%), catalytic activity (20.5%) and molecular transducer activity (9.3%). For cellular components, the dominant groups were cell (25%), cell part (25%) and organelle (15%). GO enrichment analysis identified significantly (Table II) .
KEGG pathway enrichment analysis of DEGs. In the organism, genetically distinct genes exert biological functions by coordinating with each other. Pathway enrichment analysis can identify differences in DEGs involved in the major biochemical metabolism and signal transduction pathways. Pathway enrichment analysis based on the KEGG pathway database applied hypergeometric analysis to identify the significantly enriched pathways among DEGs compared with the whole genome. KEGG pathway analysis mapped 225 DEGs to 170 pathways. The top 20 enriched pathway terms are presented in a scatter diagram (Fig. 8) . The RichFactor is the ratio between DEG numbers annotated in certain pathway terms and all gene numbers also annotated in same pathway term. A greater RichFactor indicates a greater degree of enrichment. The Q value is the corrected P-value ranging from 0-1, and its lower value indicates greater enrichment.
Discussion
The clinical characteristics of HCM are diverse, including the onset age, degree of disease and sudden death risk. Thus, it is important to further clarify the pathophysiology and investigate the molecular mechanism of the disease, as genetic diagnosis and therapy has become a new research focus and direction (23) . With continuously increasing research regarding HCM, the American College of Cardiology Foundation and American Heart Association jointly issued the Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy. The definition of HCM was updated in these guidelines, and the difference between the new definition and the previous demonstrates the importance HCM-associated genes in the diagnosis of HCM (24) . Currently, HCM is considered to be autosomal dominant disease caused by mutations in sarcomere protein genes. At present, eight genes have identified to be associated with the disease, with >1400 mutations (25) .
In the present study, a comprehensive transcriptome analysis was performed by comparing HCM tissues and normal myocardial tissue. A total of 257 DEGs were identified in which 195 genes were upregulated and 62 genes were downregulated. Among the regulated genes, 91 genes were heart-tissues specific. The current study focused on differentially expressed genes that were significantly regulated (|log2Ratio|>4). Of these genes, chordin-like 2 (CHRDL2), FGF12, and dehydrogenase/reductase (SDR family) member 7C (DHRS7C) were downregulated and seizure related 6 homolog like (SEZ6L), endothelial cell specific molecule 1 (ESM1), collagen type X α 1 chain (COL10A1), secreted frizzled related protein 4 (SFRP4), carbonic anhydrase 3 (CA3) were upregulated.
CHRDL2 encodes a member of the secreted chordin family of proteins that have a cysteine-rich pro-collagen repeat domain and associate with members of the transforming growth factor (TGF)-β superfamily (26, 27) . This gene is expressed in intracellular membrane-bounded organelles and involved in tissue development (GO:0043231). Similarly, FGF12 encoded a member of the fibroblast growth factor family, which possess broad mitogenic and cell survival activities, and are involved in a variety of biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumor Myocardial cell nuclear size may also vary. The HCM phenotype is associated with diastolic dysfunction, leading to increased susceptibility to arrhythmia, which is an important factor involved in HCM morbidity and mortality (31) . DHRS7C is strongly conserved in vertebrates, and mRNA and protein expression levels are highest in heart and skeletal muscle followed by skin, but not detectable in other organs (32, 33) . Lu et al (34) demonstrated the downregulation of DHRS7C in multiple rat heart failure models and in human heart failure patient biopsies. It provides evidence for HCM is an important cause of heart failure-associated disability over a wide range of ages on the basis of molecular genetics. CA3 was also differentially expressed between the normal group and the HCM group in the present study, and was upregulated in patients with HCM. CA3 has previously been demonstrated to be increased in the muscle tissue of hypoxia-trained athletes (35) . It is suggested that the observed increase in CA3 may be a mechanism to act as an anti-oxidizing agent against damaging molecules. Furthermore, the functions of SEZ6L, ESM1 and COL10A1 in association with HCM were unknown, however, the results of the present study may provide useful information for understanding the human physiology and the genetic etiology of HCM in further research. CORIN is a membrane-bound serine proteinase distributed in cardiac tissue, involved in modification prior to atrial peptide precursor release from cells, and is a natriuretic peptide-converting enzyme. The enzyme activates atrial natriuretic peptide, which has important role in regulating blood pressure (36) . Thus, RT-qPCR was performed to validate the RNA-Seq results of CORIN, CTFG, FGF12, FMOD and KCNIP2. Notably, relative to β-actin expression level, the expression values of CORIN ranged from 16-63 in the normal group, and 1-3.59 in patients with HCM. Thus, CORIN may be useful as a novel biomarker to detect HCM and patient stratification.
Pathway enrichment analysis of DEGs can identify the most important pathways involved in a disease. The top 20 pathways demonstrated to be associated with the DEGs in the present study are as follows: Vascular smooth muscle contraction; TGF-β signaling pathway; Staphylococcus aureus infection; renin-angiotensin system; protein digestion and absorption; prion diseases; phagosome; p53 signaling pathway; mitogen-activated protein kinase signaling pathway; malaria; leishmaniasis; HCM; focal adhesion; extracellular matrix-receptor interaction; dilated cardiomyopathy; complement and coagulation cascades; chagas disease (American trypanosomiasis); cell adhesion molecules; amoebiasis; and African trypanosomiasis. Fig. 8 presents the other pathways in addition to cardiovascular diseases and the circulatory system, such as infectious diseases, signal transduction, endocrine system, digestive system, neurodegenerative diseases, transport and catabolism, cell growth and death, cell communication, signaling molecules and interaction, immune system. Notably, six pathways were associated with infectious diseases; this phenomenon requires further investigation. Recently, a number of genetic studies have indicated that HCM is a genetic disorder associated with numerous mutations. Furthermore, HCM is considered to result from the interaction between pathogenic genes and the environment. The occurrence of HCM may involve multiple independent signaling pathways (37) . The specific treatment strategy of HCM requires targeting of specific mechanisms involved in the disease process.
Large-scale transcriptome sequencing comparing the cardiac tissue of patients with HCM and control groups was performed in the present study using an Illumina sequencing platform. A large number of DEGs were identified, which are interesting starting points for investigating the molecular mechanisms of HCM. To the best of our knowledge, this is the first study to demonstrated the changes between patients with HCM and healthy patients at the transcriptome level, which will be important to understand the major molecular mechanisms of HCM and select the key genes to investigate in the future.
